What happens when you take valproate with carnitine?
Valproate (also sold as valproic acid, divalproex, sodium valproate, and under brand names like Depakote and Depakene) is a widely prescribed broad-spectrum anticonvulsant used for epilepsy, bipolar disorder, and migraine prevention. It has a well-documented metabolic side effect: it gradually depletes the body's stores of carnitine, a small molecule that shuttles long-chain fatty acids into the mitochondria for energy production. Here is how the depletion unfolds:
- Valproate ties up carnitine. To be handled by the mitochondria, valproate forms a conjugate with carnitine called valproyl-carnitine.
- That conjugate is excreted in the urine, carrying carnitine out of the body with it.
- Valproate also reduces how much free carnitine the kidneys reabsorb, so more of it is lost in urine than would normally be the case.
- Carnitine stores fall over weeks to months of therapy, lowering plasma and tissue levels.
- Fatty-acid oxidation slows, reducing acetyl-CoA and, in turn, N-acetylglutamate, the activator the urea cycle's first enzyme needs to clear ammonia.
- Ammonia can build up in the blood (hyperammonemia), which may present as drowsiness, confusion, vomiting, tremor, or in severe cases encephalopathy.
Why is this important?
Valproate-associated hyperammonemia is not rare. Elevated ammonia is detectable in a meaningful minority of people on chronic valproate, and a smaller fraction develop overt valproate-induced hyperammonemic encephalopathy (VHE). The consequences span a wide range, from quiet cognitive slowing to, rarely, coma.
The point is not to frighten anyone off an effective medication. Most people on valproate never develop symptomatic carnitine depletion. But certain groups warrant closer attention: children, people on more than one anticonvulsant, those with intellectual disability, anyone with a previously unrecognized urea cycle disorder, and people on high-dose or long-term therapy. In these settings, carnitine status is worth knowing, because correcting it is one of the few clearly evidence-based supplement additions to anticonvulsant care.
What should you do?
This is a medication issue, so the conversation belongs with your neurologist or psychiatrist rather than something you handle alone.
Before any change: Ask your prescriber whether your situation (long-term therapy, high dose, polytherapy, a child, or a known metabolic disorder) warrants checking a fasting ammonia level and a free-to-total carnitine ratio. Agree together on whether L-carnitine makes sense and what dose is right for you. Do not start carnitine on your own.
Every day, once you and your prescriber have agreed on a plan: Take L-carnitine as directed, usually divided across the day, and keep taking your valproate exactly as prescribed. Note any fatigue, brain fog, drowsiness, or worsening tremor in Pilora so you have a record to share.
After any change: If new or worsening symptoms appear, contact your prescriber and ask whether a repeat ammonia and carnitine check is warranted. Bring objective data (ammonia, free and total carnitine, liver enzymes) to follow-up visits. Never stop or change your valproate dose on your own, since uncontrolled seizures or mood episodes are a far greater risk than carnitine depletion.
Which specific products are affected?
The interaction applies to all valproate-containing prescription drugs, including Depakote, Depakote ER, Depakote Sprinkles, Depakene, Depacon, divalproex sodium, sodium valproate, and valproic acid. Both immediate-release and extended-release formulations cause carnitine depletion, although extended-release products may produce somewhat smaller swings in plasma ammonia.
On the supplement side, carnitine is sold as L-carnitine tartrate, acetyl-L-carnitine (ALCAR), propionyl-L-carnitine, and as the prescription form levocarnitine (Carnitor). For valproate-related depletion, L-carnitine tartrate or prescription levocarnitine are the usual choices; acetyl-L-carnitine crosses into the brain more readily and is sometimes preferred when cognitive symptoms predominate, though it is less studied for this specific purpose. Avoid D-carnitine or DL-carnitine mixtures, since only the L-isomer is biologically active.
The science behind it
The sources below directly support the mechanism and the clinical fix.
- Maldonado C, et al. (J Int Med Res, 2017) — a case report describing a woman whose chronic valproate-induced hyperammonemia normalized after about a month of oral L-carnitine, without needing to discontinue her anticonvulsant. PMC5536406
- Nakamura M and Nagamine T (Innov Clin Neurosci, 2015) — a prospective study of psychiatric patients on valproic acid in which levocarnitine supplementation reduced hyperammonemia and improved mental status, supporting carnitine repletion in valproate-induced hyperammonemia. PMC4655895
- Earlier clinical studies (1990s) — clinical work in valproate-treated patients linked valproate therapy to lowered carnitine levels and altered ammonia handling, providing the human grounding for L-carnitine repletion. PMID 9443096, PMID 8190571
Much of the strongest evidence is case reports and clinical series rather than large randomized trials, so the supplementation case is well-grounded for symptomatic depletion but less settled for routine prophylaxis in low-risk patients.
Frequently Asked Questions
Does everyone on valproate need carnitine?
No. Most people on valproate do not develop symptomatic carnitine depletion. Supplementation is mainly considered for higher-risk groups or for those with elevated ammonia or carnitine deficiency, and the decision should be made with your prescriber.
How would I know if my carnitine is low?
You usually cannot tell from symptoms alone, since fatigue, brain fog, and drowsiness are nonspecific. Your prescriber can order a fasting ammonia level and a free-to-total carnitine ratio to clarify.
Can I just buy L-carnitine and start taking it?
It is better not to self-start, especially at higher doses. The right form and dose depend on your situation, and your prescriber should guide it. Higher doses can cause a fishy body odor, nausea, and diarrhea.
Will carnitine let me stay on valproate?
Often yes. In clinical reports, correcting carnitine and ammonia allowed people to continue valproate. But that judgment belongs to your prescriber, who weighs your seizure or mood control against the metabolic picture.
Which form of carnitine is best?
L-carnitine tartrate or prescription levocarnitine are the usual choices for valproate-related depletion. Acetyl-L-carnitine is sometimes used when cognitive symptoms dominate. Avoid D- or DL-carnitine mixtures.
Is hyperammonemia an emergency?
It can be. Marked confusion, severe drowsiness, persistent vomiting, or unresponsiveness in someone on valproate needs urgent medical attention, not a supplement adjustment at home.
Key takeaways
- Valproate steadily depletes carnitine through urinary loss as valproyl-carnitine and reduced renal reabsorption.
- The resulting shortfall can impair the urea cycle and contribute to raised ammonia, liver stress, and fatigue.
- Children, those on polytherapy, and people on high-dose or long-term therapy are at greatest risk.
- L-carnitine has reversed valproate-related hyperammonemia in clinical reports and is recommended for symptomatic cases.
- Start and dose carnitine only under medical supervision, and never stop or change valproate on your own.